AB-86-GB42_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, 3-(3-(2-(4-Fluorophenyl)pyridin-4-yl)imidazo[1,2-a]pyridin-7-yl)-N-methylbenzamide, ALK5 inhibitor targeting TGFBR1 (Novartis, 68487333)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/68487333
Similar Terms
Downloads & Tools

Genes

12 genes differentially expressed following the AB-86-GB42_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
CDPF1 cysteine-rich, DPF motif domain containing 1 0.460939
CITED2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 0.244974
LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 0.200066

decreased expression

Symbol Name Standardized Value
CLPTM1L CLPTM1-like -1.96663
PMEPA1 prostate transmembrane protein, androgen induced 1 -1.47391
TPM1 tropomyosin 1 (alpha) -0.869646
SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 -0.434822
HPS4 Hermansky-Pudlak syndrome 4 -0.356072
MAK16 MAK16 homolog (S. cerevisiae) -0.342816
GADD45B growth arrest and DNA-damage-inducible, beta -0.221039
PDXK pyridoxal (pyridoxine, vitamin B6) kinase -0.218498
MLF1 myeloid leukemia factor 1 -0.218498